888.886.9354
cs@xtantmedical.com
664 Cruiser Lane
Belgrade MT, 59714
BELGRADE, Mont., Jan. 13, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products
Record Fourth Quarter 2016 Revenue is estimated to be at least $24.5 million which represents 10.0% year on year growth Full Year 2016 Revenue is
Belgrade, MT, November 22, 2016 – Xtant Medical Holdings, Inc. (NYSE MKT: XTNT), a leader in the development of regenerative medicine products and medical devices,
BELGRADE, Mont., Nov. 17, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products
BELGRADE, Mont., Nov. 15, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products
Belgrade, MT, November 15, 2016 – Xtant Medical Holdings, Inc. (NYSE MKT: XTNT), a leader in the development of regenerative medicine products and medical devices,
Belgrade, MT, November 11, 2016 – Xtant Medical Holdings, Inc. (NYSE MKT: XTNT), a leader in the development of regenerative medicine products and medical
BELGRADE, Mont., June 16, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical
BELGRADE, Mont. and DALLAS, June 08, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products
New facility provides additional working capital to continue Company market expansion plans BELGRADE, Mont., May 26, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE
